Pharma major GlaxoSmithKline (GSK) and global IT giant Tata Consultancy Services (TCS) have entered into a multi-million dollar contract for setting up a global drug development center in Mumbai.
Under the contract, TCS will provide a variety of services in clinical research, including clinical data management and clinical submissions support.
"GSK has chosen to partner with TCS because of its strong record in knowledge process outsourcing, underpinned by operational excellence," Amber Salzman, senior vice president, development operations, GSK, said in a statement Tuesday.
According to Salzman, the partnership will also help deliver new medicines to patients.
GSK, under this alliance, also plans to expand capacity in response to increased efficiency demands, leverage the high-quality talent pool in India, and benefit from cost and process improvements.